Global Liver Institute CEO Praises U.S. House Subcommittee, Organ Procurement Organization Action to Help Transplant Patients (Washington, D.C., Tuesday, May 4, 2021)—Donna Cryer, president and CEO...
Global Liver Institute
Two Global Liver Institute Witnesses to Testify at U.S. House of Representatives Subcommittee Hearing on Reforming the Organ Transplantation System
(Washington, D.C., Friday, April 30, 2021)—Two witnesses from Global Liver Institute (GLI) will testify at a key U.S. House of Representatives subcommittee hearing on the need to...
USPSTF Must Include Link to Liver Disease in Recommendation on Screening for Diabetes
(Washington, D.C., April 13, 2021) – Global Liver Institute (GLI) and many of the leaders of the liver, diabetes and obesity advocacy community have submitted a formal letter and comments to...
Global Liver Institute Offering Multilingual Materials and Grants for International NASH Day on June 10
(Washington, D.C., March 4, 2021) – Global Liver Institute (GLI) is pleased to announce that the 2021 International NASH Day (#NASHday) will be held on June 10, 2021, with the...
COVID-19 Vaccine Guidance for Liver Transplant Recipients
As more Americans have received at least one dose of a COVID-19 vaccine than have tested positive for the virus1, we are seeing some hope for defeating the pandemic with science. While different...
Global Liver Institute Requests Urgent Implementation of Organ Procurement Organization Reform Measures
(Washington, D.C., February 18, 2021) Today, Global Liver Institute (GLI) submitted a letter directly to U.S. Department of Health and Human Services (HHS) Secretary-Designee Xavier...
How the New 117th Congress and Presidential Administration Impacts Liver Health Policy
POLICY PERSPECTIVE The 2020 election not only resulted in a new president and vice president, but also 66 new Members of Congress. The 117th Congress will have 57 new U.S. Representatives from 28...
Global Liver Institute Announces First Annual Rare Liver Diseases Month
(Washington, D.C., February 1, 2021) – Global Liver Institute (GLI), in their mission to improve the lives of individuals and families impacted by liver disease, has announced February 2021 as...
Global Liver Institute’s Response to FDA Briefing on NASH Drug Development
(Washington, D.C., January 29, 2021) Thank you to the Food and Drug Administration (FDA) for the informative briefing earlier today titled, “Regulatory Perspectives for Development of Drugs for...
Global Liver Institute’s Response to Washington, DC, Vaccine Distribution Strategy
(Washington, D.C., January 25, 2021) On January 21, DC Health announced the plan to open up vaccine access, possibly as soon as February, to an expansive population including habitual smokers...
Recent News